NASDAQ
Kyverna Therapeutics, Inc. (KYTX) has a fcf yield of -36.95% as of Friday, May 29, 2026. This represents a 65.53% decrease compared to its 12-month average of -22.32%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.